Navigation Links
NORTHWEST BIO Announces Positive Third Quarter Progress
Date:10/6/2011

review by the Company, as well as through other distribution channels.

Linda Powers, CEO of NORTHWEST BIO, commented that "It is gratifying to see that the expanded management team put in place in June is moving the GBM clinical trial forward at an accelerating rate, while taking important steps toward strengthening our investor and media outreach."  

About Northwest Biotherapeutics

Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis in both the US and Europe.  The Company has a broad platform technology for dendritic cell-based vaccines.  The Company's lead clinical trial is a 240-patient Phase II trial in newly diagnosed Glioblastoma multiforme ("GBM"), the most aggressive and lethal brain cancer.  The Company also previously received clearance from the FDA for a 612-patient Phase III trial in prostate cancer, and clearance from the FDA for Phase I trials in multiple other cancers.  The Company has also conducted a Phase I/II trial with DCVax® for recurrent metastatic ovarian cancer.  For further information about clinical sites and about the Company, please visit the Company's web site at www.nwbio.com.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients with GBM using DCVax® and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, ther
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011
2. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
3. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
4. Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner
5. Northwest Biotherapeutics Announces Change and Expansion of Management Team
6. Northwest Biotherapeutics Announces Series of Financing Arrangements
7. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
8. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
9. Northwest Biotherapeutics Addresses Recent Market Activity
10. Cell Therapeutics, Inc. (CTI) to Present at Life Science Innovation Northwest
11. Registration Open for WBBAs Life Science Innovation Northwest 2011 Event Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 03, 2015 , ... The latest addition to the Mettler-Toledo PCE ... automatically. Companies in the pharmaceutical and healthcare industry can use the LSS to print ... The Label Serialization Station can be fully integrated into the production line and is ...
(Date:9/3/2015)... Texas , Sept. 3, 2015  Vermillion, Inc. ... on gynecologic disease, today announced that Herbert Fritsche ... subsidiary, ASPiRA LABS, is the recipient of the 2015 ... and Biomarkers (ISOBM) for outstanding contributions to the field ... the award on October 5 th in Zakopane, ...
(Date:9/3/2015)... September 3, 2015 According to ... System (LC (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, ... Filters, Vials) - Analysis & Global Forecasts to 2020", ... to reach around 9.223 Billion by 2020 from USD ... Browse 141 tables and 36 figures spread ...
(Date:9/3/2015)... ... 2015 , ... If you plan to attend the 27th annual Tradeline ... want to sign up for the tour of Framingham State University's newest addition to ... through of the (8) chemistry teaching labs that are exclusively utilizing (49) filtered ...
Breaking Biology Technology:Print and Verify Labels On The Production Line With New Label Serialization Stations 2Print and Verify Labels On The Production Line With New Label Serialization Stations 3Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 2Chromatography Instruments Market Worth $ 9.223 Billion by 2020 3Chromatography Instruments Market Worth $ 9.223 Billion by 2020 4Erlab Invites You to Tour the Largest Installation of Filtered Fume Hoods in the World 2
... Naviscan PET Systems, Inc., a,privately held company that ... newest installation of the PEM Flex(TM) Solo,II scanner ... New York.,This installation marks the beginning of a ... PET Imaging that will bring organ specific,molecular imaging ...
... Clearance for Axxent(R), System Strengthens the ... SUNNYVALE, Calif., May 21 Xoft, Inc., ... U.S. Food & Drug Administration,(FDA) for applicators to ... the treatment of endometrial cancer. Previously,cleared for accelerated ...
... to Jointly Award $200,000 in research funding, ... (CPF) and the American Thoracic Society (ATS), the ... sleep,physicians, today announced the expansion of their research ... available two new two-year,$100,000 awards for researchers in ...
Cached Biology Technology:Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 2Naviscan PET Systems and Rockville PET Imaging Partner to Bring a New Breast Imaging Technology to New York 3FDA Clears New Applicators for Endometrial Cancer Treatment With Xoft's Axxent(R) Electronic Brachytherapy System 2FDA Clears New Applicators for Endometrial Cancer Treatment With Xoft's Axxent(R) Electronic Brachytherapy System 3FDA Clears New Applicators for Endometrial Cancer Treatment With Xoft's Axxent(R) Electronic Brachytherapy System 4Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 2Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010 3
(Date:8/25/2015)... CITY and BELLEVUE, Wash. ... leader in advanced robotic systems, announced today it will ... unmanned ground vehicle (UGV), at the National Tactical Officers ... The Guardian S is the first-ever ... culmination of years of research and in-field trials and ...
(Date:8/24/2015)... -- Based on its recent analysis of the biometric products market, ... Company of the Year Award. DERMALOG is the leading German ... Africa . It has particularly gained prominence in ... of the largest biometric mass applications in the world, and ... of Nigeria with its biometric products. ...
(Date:8/20/2015)... , Aug. 20, 2015   Sensory, Inc ... improving the user experience and security of consumer ... today announced that its TrulySecure™ is ... software to be FIDO Certified™. The ... compliance with the FIDO UAF (Universal Authentication Framework) ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 2Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 3Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 4Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 5Frost & Sullivan Applauds DERMALOG's Rise as the Supplier of Best-in-class Biometric Solutions in Africa 6TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5
... also available in Spanish . , ... of Experimental Sciences of the University of ... this reason, immigrant teenagers have a lower probability of suffering ... eating habits. The study has not only analysed for the ...
... of UAB geneticists, doctors and biostatisticians has received $5.7 ... and test new treatments for neurofibromatosis, or NF. ... group called the NF Consortium. The coalition formed more ... clinical trials held across the nation looking at new ...
... the plot to blow up trans-Atlantic airlines with liquid explosives ... pressure on the airline industry, and Homeland Security, to find ... on airline passengers, but also to figure out what they ... Directorate (S&T) is teaming with scientists at the Los Alamos ...
Cached Biology News:Study reveals that immigrant teenagers eat better than Spanish teenagers 2UAB wins $5.7M neurofibromatosis grant 2UAB wins $5.7M neurofibromatosis grant 3Menace in a bottle 2
... Convenient, easy-to-use kits for arraying proteins ... using common lab equipment. DiscoverLight Protein ... of your protein, cell lysate or ... The kits include specially designed nitrocellulose ...
Request Info...
... AP Conjugate Stabilizer is an aqueous ... protein and other non-toxic stabilizing chemicals ... pH 5.5 6.5. This ... methylisothiazolone and 0.02% bromonitrodioxane as a ...
MAb to Myoglobin Cardiac...
Biology Products: